An influenza vaccine previously available only to Australians aged 65 and over has now been approved for adults aged 50 and above, providing an additional option for people at greater risk of serious illness from the flu.
Fluad, an adjuvanted influenza vaccine, has been funded under the National Immunisation Program since 2018 for Australians aged 65 and over, with millions of seniors receiving the free vaccine each year.
Health experts say people aged 50 and over can face an increased risk of severe flu due to natural changes in the immune system and the growing likelihood of chronic health conditions such as diabetes, heart disease and respiratory illnesses.
Each year, influenza is estimated to cause more than 13,500 hospitalisations and over 3,000 deaths among Australians aged 50 and over. Despite this, only about one in three Australians aged 50 to 64 received a flu vaccine in 2025.
Public Health Physician and GP Professor Paul Van Buynder said many people underestimate their flu risk as they get older.
“If you’re over 50, your immune system has changed – even if your lifestyle hasn’t,” he said. “Catching flu could mean hospitalisation or worse, which is why it’s important to talk to your doctor or pharmacist about the vaccine option that’s right for you.”
Dr Nick Coatsworth from Patients Australia said many Australians in their 50s still viewed themselves as healthy and active, often overlooking the potential impact of influenza.
“There’s really no such thing as ‘just the flu’,” he said. “Even a mild case can leave you feeling unwell for weeks and disrupt work, family and social activities.”
Influenza vaccination is recommended for everyone aged six months and over. Free vaccines remain available under the National Immunisation Program for eligible groups, including people aged 65 and over, young children, pregnant women, Aboriginal and Torres Strait Islander people, and those with certain medical conditions.